カテゴリー： 世界, 医療/バイオ, Bizwit Research & Consulting

世界の避妊薬市場2022-2029：製品別（経口型、注射型、パッチ型）、流通チャネル別、地域別

【英語タイトル】Global Contraceptive Drugs Market Size study & Forecast, by Product (Oral, Injectable , Patches), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channels & NGOs and Others) and Regional Analysis, 2022-2029

Bizwit Research & Consultingが出版した調査資料（BZW23JUN061）・商品コード：BZW23JUN061
・発行会社（調査会社）：Bizwit Research & Consulting
・発行日：2023年5月20日
・ページ数：約200
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用、印刷不可）USD4,950 ⇒換算￥752,400見積依頼/購入/質問フォーム
Enterprisewide（同一法人内共有可）USD6,250 ⇒換算￥950,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Bizwit Research社の本調査資料では、2021年に165.9億ドルであった世界の避妊薬市場規模が、2022年〜2029年にかけて年平均7.4%で成長すると予測しています。本資料は、避妊薬の世界市場について市場実態を明らかにするとともに、今後の動向を展望したレポートです。エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析（新型コロナウイルス感染症の影響）、製品別（経口型、注射型、パッチ型）分析、流通チャネル別（病院薬局、小売薬局、診療所、オンライン、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、その他地域）分析、競争分析、調査プロセスなどの項目で構成されています。また、主要参入企業として、Piramal Enterprises Ltd.、Organon group of companies 、Johnson & Johnson Services, Inc.、AbbVie Inc.、Pfizer Inc.、Teva Pharmaceutical Industries Ltd.、 Viatris Inc.、 Amneal Pharmaceuticals, Inc.、Bayer AG、Agile Therapeutics.などの情報が含まれています。

・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析（新型コロナウイルス感染症の影響）
・世界の避妊薬市場規模：製品別
- 経口型避妊薬の市場規模
- 注射型避妊薬の市場規模
- パッチ型避妊薬の市場規模
・世界の避妊薬市場規模：流通チャネル別
- 病院薬局チャネルの市場規模
- 小売薬局チャネルの市場規模
- 診療所チャネルの市場規模
- オンラインチャネルの市場規模
- その他チャネルの市場規模
・世界の避妊薬市場規模：地域別
- 北米の避妊薬市場規模
- ヨーロッパの避妊薬市場規模
- アジア太平洋の避妊薬市場規模
- 中南米の避妊薬市場規模
- その他地域の避妊薬市場規模
・競争分析
・調査プロセス

Global Contraceptive Drugs Market is valued approximately USD 16.59 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.4% over the forecast period 2022-2029. Contraceptive Drugs are consumed by female for birth control. The Contraceptive Drugs market is expanding because of factors such as increasing prevalence of unwanted pregnancies and increasing prevalence of sexually transmitted diseases (STDs). However, rising prevalence of infertility and adverse effects associated with the use of contraceptive drugs and devices may halt market growth.

Throughout the forecast period, the market growth is anticipated to be driven by the rising incidence of Sexually Transmitted Diseases (STDs) and the rising number of women with unmet need for contraceptive medications & devices. Almost 1.1 billion women worldwide in 2019 who are reproductive age (15 to 49 years) need family planning, according to the World Health Organization. Over 842 million of them use contraceptive techniques for family planning, and 270 million of them have unmet contraception needs. Furthermore, The Department of Economic and Social Affairs, Population Division of the United Nations reports that in 2019 that there are 1.9 billion women in the world who are reproductive age (15–49). Around 80 million people utilize conventional methods, while about 842 million women use contemporary contraception, including oral medications and injectables. In addition, growing awareness regarding contraceptive drugs leads to product demand creating a lucrative growth to the market. Along with these, wide availability of reimbursement policies in developed countries is expected to fuel the market adoption rate in the forecasted period.

The key regions considered for the Global Contraceptive Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region’s increasing disease prevalence. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for biosimilar development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market player included in this report are:
Piramal Enterprises Ltd.
Organon group of companies
Johnson & Johnson Services, Inc.
AbbVie Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
Amneal Pharmaceuticals, Inc.
Bayer AG
Agile Therapeutics.

Recent Developments in the Market:
 In February 2020, The U.S. FDA has authorized Agile Therapeutics to commercialize Twirla (levonorgestrel and ethinyl estradiol), a transdermal patch for women.
 In January 2020, Bayer AG and Daré Bioscience, Inc. have signed a licence agreement to distribute Ovaprene after the U.S. Food and Drug Administration gives the experimental contraception medicine market clearance.

Global Contraceptive Drugs Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, Distribution Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Oral
Injectable
Patches

By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Clinics
Online Channels
Public Channels & NGOs
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Contraceptive Drugs Market, by Region, 2019-2029 (USD Billion)
1.2.2. Contraceptive Drugs Market, by Product, 2019-2029 (USD Billion)
1.2.3. Contraceptive Drugs Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Contraceptive Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Contraceptive Drugs Market Dynamics
3.1. Contraceptive Drugs Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Government and NGO initiatives to promote contraceptive methods
3.1.1.2. Increasing prevalence of unwanted pregnancies
3.1.2. Market Challenges
3.1.2.1. Rising prevalence of infertility
3.1.2.2. Adverse effects associated with the use of contraceptive drugs and devices
3.1.3. Market Opportunities
3.1.3.1. Increasing prevalence of sexually transmitted diseases (STDs)
Chapter 4. Global Contraceptive Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Contraceptive Drugs Market, by Product
6.1. Market Snapshot
6.2. Global Contraceptive Drugs Market by Product, Performance – Potential Analysis
6.3. Global Contraceptive Drugs Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
6.4. Contraceptive Drugs Market, Sub Segment Analysis
6.4.1. Oral
6.4.2. Injectable
6.4.3. Patches
Chapter 7. Global Contraceptive Drugs Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global Contraceptive Drugs Market by Distribution Channel, Performance – Potential Analysis
7.3. Global Contraceptive Drugs Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
7.4. Contraceptive Drugs Market, Sub Segment Analysis
7.4.1. Hospital Pharmacy
7.4.2. Retail Pharmacy
7.4.3. Clinics
7.4.4. Online Channels
7.4.5. Public Channels & NGOs
7.4.6. Others
Chapter 8. Global Contraceptive Drugs Market, Regional Analysis
8.1. Contraceptive Drugs Market, Regional Market Snapshot
8.2. North America Contraceptive Drugs Market
8.2.1. U.S. Contraceptive Drugs Market
8.2.1.1. Product breakdown estimates & forecasts, 2019-2029
8.2.1.2. Distribution Channel breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Contraceptive Drugs Market
8.3. Europe Contraceptive Drugs Market Snapshot
8.3.1. U.K. Contraceptive Drugs Market
8.3.2. Germany Contraceptive Drugs Market
8.3.3. France Contraceptive Drugs Market
8.3.4. Spain Contraceptive Drugs Market
8.3.5. Italy Contraceptive Drugs Market
8.3.6. Rest of Europe Contraceptive Drugs Market
8.4. Asia-Pacific Contraceptive Drugs Market Snapshot
8.4.1. China Contraceptive Drugs Market
8.4.2. India Contraceptive Drugs Market
8.4.3. Japan Contraceptive Drugs Market
8.4.4. Australia Contraceptive Drugs Market
8.4.5. South Korea Contraceptive Drugs Market
8.4.6. Rest of Asia Pacific Contraceptive Drugs Market
8.5. Latin America Contraceptive Drugs Market Snapshot
8.5.1. Brazil Contraceptive Drugs Market
8.5.2. Mexico Contraceptive Drugs Market
8.5.3. Rest of Latin America Contraceptive Drugs Market
8.6. Rest of The World Contraceptive Drugs Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Piramal Enterprises Ltd.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Organon group of companies
9.2.3. Johnson & Johnson Services, Inc.
9.2.4. AbbVie Inc.
9.2.5. Pfizer Inc.
9.2.6. Teva Pharmaceutical Industries Ltd.
9.2.7. Viatris Inc.
9.2.8. Amneal Pharmaceuticals, Inc.
9.2.9. Bayer AG
9.2.10. Agile Therapeutics
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

List of Tables
TABLE 1. Global Contraceptive Drugs Market, report scope
TABLE 2. Global Contraceptive Drugs Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Contraceptive Drugs Market estimates & forecasts by Product 2019-2029 (USD Billion)
TABLE 4. Global Contraceptive Drugs Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
TABLE 5. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Contraceptive Drugs Market
TABLE 70. List of primary sources, used in the study of global Contraceptive Drugs Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable

★調査レポート[世界の避妊薬市場2022-2029：製品別（経口型、注射型、パッチ型）、流通チャネル別、地域別] (コード：BZW23JUN061)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の避妊薬市場2022-2029：製品別（経口型、注射型、パッチ型）、流通チャネル別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の揚げ物システム市場予測2023-2029：真空型、連続型、バッチ型
  • TEMモード同軸リラミック共振器の世界市場2023-2029：インサート型、パッチ型
  • TE・TMモード誘電体セラミック共振器の世界市場2023-2029：インサート型、パッチ型
  • 世界の多発性硬化症（MS）治療薬市場2022-2029：薬剤クラス別（免疫調節剤、免疫抑制剤、インターフェロン）、投与経路別、流通チャネル別、地域別
  • 世界の体部白癬治療薬市場2022-2029：薬剤別（抗真菌剤、その他）、投与経路別（経口、局所、非経口）、エンドユーザー別（病院、在宅医療、専門クリニック）、流通チャネル別（病院薬局、オンライン薬局、小売薬局）、地域別
  • 世界の幻覚剤市場2022-2029：薬物種類別（ガンマヒドロキシ酪酸（GHB）、ケタミン、シロシビン、リゼルギン酸ジエチルアミド（LSD）、3,4-メチレンジオキシメタンフェタミン、その他）、用途別（治療抵抗性うつ病、アヘン中毒、心的外傷後ストレス障害、ナルコレプシー、パニック障害、その他）、流通チャネル別（病院薬局、小売薬局、その他）、地域別
  • 世界のジストニア治療薬市場2022-2029：治療薬別（抗けいれん薬、ドーパミン作動薬、GABA作動薬、その他）、投与経路別、流通チャネル別、地域別
  • ハイシアーリアクター（HSR）のグローバル市場2023年：インライン型、バッチ型、その他
  • 世界の女性用不妊治療薬市場2022-2029：治療法別（ゴナドトロピン、クロミフェン、レトロゾール、メトホルミン、その他）、投与方法別、流通チャネル別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆